Role of iron in dermatology

Dermatology

Volumn 200, Issue 2, 2000, Pages 156-159

  Simonart, T ^a   Van Vooren, J P ^a   Parent, D ^a   Heenen, M ^a   Boelaert, J R ^b  

^a ERASME HOSPITAL   (Belgium)

^b General Hospital St Jan   (Belgium)

Author keywords

Infection; Iron; Kaposi's sarcoma; Pigmentation; Porphyria; Reactive oxygen species; Tumour

Indexed keywords

IRON; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; CONTACT DERMATITIS; HUMAN; PHAGOCYTE; PIGMENT DISORDER; PORPHYRIA; PRIORITY JOURNAL; SHORT SURVEY; SKIN CANCER; SKIN DISEASE; SKIN INFECTION; SKIN INFLAMMATION;

EID: 0034128035     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018355     Document Type: Short Survey

References (36)

1. Aisen P, Listowsky I: Iron transport and storage proteins. Annu Rev Biochem 1980;49:357-393.
2. Sussman HH: Iron in cancer. Pathobiology 1992;60:2-9.
3. Cazzola M, Bergamaschi G, Dezza L, Arosio P: Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation. Blood 1990;75:1903-1919.
4. Reichard P, Ehrenberg A: Ribonucleotide reductase: A radical enzyme. Science 1983;221: 514-519.
5. Robert P, Zurcher H, Schmidli B: Etudes sur la pigmentation. Dermatologica 1953;106:201-218.
6. Traub EF, Tennen JS: Permanent pigmentation following application of iron salts for treatment of ivy poisoning. JAMA 1936;106:1711-1712.
7. Olmstead-Lund HZ, Leonard DD: Monsel's solution: A histologic nuisance. J Am Acad Dermatol 1980;3:492-498.
8. Doutre MS, Beylot-Barry M, Beylot C, Vergier B, Surlevé-Bazeille JE: Gluteal pigmentation after intramuscular iron injections. Dermatology 1996;192:187-188.
9. Granstein RD, Sober AJ: Drug- and heavy metal-induced hyperpigmentation. J Am Acad Dermatol 1981;5:1-18.
10. Pepine M, Flowers FP, Ramos-Caro FA: Extensive cutaneous hyperpigmentation caused by minocyclinc. J Am Acad Dermatol 1993;2: 292-295.
11. Hare PJ: A case of occupational iron pigmentation of the skin. Br J Dermatol 1951;63:63-66.
12. Lucker GPH, Koopman RJJ, Vandervalk PGM: A regional trade-related dermatosis. Contact Dermatitis 1993;29:217-218.
13. Rubianes EI, Sanchez JC: Granulomatous dermatitis to iron oxide after permanent pigmentation of the eyebrows. J Dermatol Surg Oncol 1993;19:14-16.
14. Herbich GJ: Ultrapulse carbon dioxide laser treatment of an iron oxide flesh-colored tattoo. Dermatol Surg 1997;23:60-61.
15. Kurban RS, Goldstein JA, Bhawan J: Earring-induced localized iron tattoo. J Am Acad Dermatol 1991;24:788-789.
16. Baer RL: Allergic contact sensitization to iron. J Allergy Clin Immunol 1973;51:35-38.
17. Zugerman C: Contact dermatitis to yellow iron oxide. Contact Dermatitis 1985;13:107-109.
18. Trenam CW, Blake D, Morris CJ: Skin inflammation: Reactive oxygen species and the role of iron. J Invest Dermatol 1992;99:675-682.
19. Cheatle T: Venous ulceration and free radicals. Br J Dermatol 1991;124:508.
20. Bissett DL, McBride JF: Synergistic topical photoprotection by combination of the iron chelator 2-furildioxime and sunscreen. J Am Acad Dermatol 1996;35:546-549.
21. Fuller JD, Williams HJ, McRorie TI: Necrotic bilateral buttocks ulcerations occurring after multiple intramuscular iron dextran injections. Arch Dermatol 1988;124:1722-1723.
22. O'Reilly FM, Darby C, Fogarty J, Tormey W, Kay EW, Leader M, Murphy GM: Screening of patients with iron overload to identify hemochromatosis and porphyria cutanca tarda. Arch Dermatol 1997;133:1098-1101.
23. Milligan A, Graham-Brown RA, Sarkany I, Baker H: Erythropoietic protoporphyria exacerbated by oral iron therapy. Br J Dermatol 1988;119:63-66.
24. Weinberg ED: Iron withholding: A defense against viral infections. Biometals 1996;9:393-396.
25. Boelaert JR, Weinberg GA, Weinberg ED: Altered iron metabolism in HIV infection: Mechanisms, possible consequences, and proposals for management. Infect Agents Dis 1996:5:36-46.
26. Boelaert JR: Iron and infection. Acta Clin Belg 1996;51:213-221.
27. Weinberg ED: The role of iron in cancer. Eur J Cancer Prev 1996;5:19-36.
28. Robertson AG, Dick WC: Intramuscular iron and local oncogenesis. Br Med J 1977;i:947-949.
29. Stevens RG, Graubard BI, Micozzi MS, Neriisshi K, Blumberg BS: Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int J Cancer 1994;56: 364-369.
30. Ziegler JL: Endemic Kaposi's sarcoma in Africa and local volcanic soils. Lancet 1993;342: 1348-1351.
31. Simonart T, Noel JC, Andrei G, Parent D, Van Vooren JP, Hermans P, Lunardi-Yskandar Y, Lambert C, Dieye T, Farber CM, Liesnard C, Snoeck R, Heenen M, Boelaert JR: Iron as a potential cotactor in the pathogenesis of Kaposi's sarcoma. Int J Cancer 1998;78:720-726.
32. Simonart T, Van Vooren JP, Herbauts J, Boelaert JR: High prevalence of Kaposi's sarcoma in Iceland and the Faroe Islands (letter). Br J Cancer 1999;79:373.
33. Lunardi-Iskandar Y, Bryant JL, Zeman RA, Lam VH, Samaniego F, Besnier JM, Hermans P, Thierry AR, Gill P, Gallo RC: Tumorigenesisand metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 1995; 375:64-68.
34. Oettle AG: Geographical and racial differences in the frequency of Kaposi's sarcoma as evidence of environmental or genetic causes. Acta Unio Int Cancrum 1962;18:330-363.
35. Gordeuk VR, Mukiibi J, Hasstedt SJ, Samowitz W, Edwards CQ, West G, Ndambire S, Emmanuel J, Nkanza N, Chapanduka Z, Randall M, Boone P, Romano P, Martell RW, Yamashita T, Effler P, Brittenham G: Iron overload in Africa: Interaction between a gene and dietary iron content. N Engl J Med 1996; 326:95-100.
36. Folkman J: Clinical applications of research on angiogenesis. N Engl J Med 1995;333:1757-1763.